ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 52,979 | 48,470 | 49,774 | 47,966 | 51,337 |
| Cost of Goods | 20,118 | 20,695 | 21,804 | 17,795 | 15,002 |
| Gross Profit | 32,861 | 27,775 | 27,970 | 30,171 | 36,335 |
| Operating Expenses | 30,177 | 39,777 | 36,616 | 35,637 | 29,009 |
| Operating Income | 2,802 | -11,307 | -7,842 | -4,671 | 7,328 |
| Interest Expense | 2,510 | 2,356 | 2,032 | 2,870 | 3,336 |
| Other Income | -229 | -116 | 10 | -111 | -33 |
| Pre-tax Income | 63 | -13,779 | -9,864 | -7,652 | 3,959 |
| Income Tax | -371 | -1,443 | -2,853 | -2,817 | 64 |
| Net Income Continuous | 434 | -12,336 | -7,011 | -4,835 | 3,895 |
| Net Income | $434 | $-12,336 | $-7,011 | $-4,835 | $3,895 |
| EPS Basic Total Ops | 0.04 | -1.03 | -0.59 | -0.40 | 0.32 |
| EPS Basic Continuous Ops | 0.04 | -1.03 | -0.59 | -0.41 | 0.33 |
| EPS Diluted Total Ops | 0.04 | -1.03 | -0.59 | -0.39 | 0.32 |
| EPS Diluted Continuous Ops | 0.04 | -1.03 | -0.59 | -0.39 | 0.32 |
| EBITDA(a) | $14,160 | $-109 | $3,341 | $4,893 | $16,801 |